Dienedione

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Dienedione
Dienedione.svg
Clinical data
Other names19-Nor-4,9(10)-androstadienedione; Estradienedione, 19-Norandrosta-4,9(10)-diene-3,17-dione; Estra-4,9(10)-diene-3,17-dione
Routes of
administration
Oral
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.112.341 Edit this at Wikidata
Chemical and physical data
FormulaC18H22O2
Molar mass270.372 g·mol−1
3D model (JSmol)
  (verify)

Dienedione, also known as estra-4,9-diene-3,17-dione, is a synthetic, orally active anabolic-androgenic steroid (AAS) of the 19-nortestosterone group that was never introduced for medical use. It is thought to be a prohormone of dienolone.[1] The drug became a controlled substance in the US on January 4, 2010,[2] and is classified as a Schedule III anabolic steroid under the United States Controlled Substances Act. Previous to this, it was sold as a bodybuilding supplement within the United States, and often mistakenly marketed as a prohormone for trenbolone, a veterinary steroid. Prior to its scheduling, it was part of a number of supplements that were seized during FDA enforcement of Bodybuilding.com for selling unapproved new drugs.[3] The actual active metabolite, dienolone, is almost identical to trenbolone structurally, but lacks the C11 double bond.

See also[edit]

References[edit]

  1. ^ "Rules - 2009 - Final Rule: Classification of Three Steroids as Schedule III Anabolic Steroids Under the Controlled Substances Act". www.deadiversion.usdoj.gov. Retrieved 1 June 2017.
  2. ^ "Rules - 2009 - Final Rule: Classification of Three Steroids as Schedule III Anabolic Steroids Under the Controlled Substances Act". www.deadiversion.usdoj.gov. Retrieved 1 June 2017.
  3. ^ Affairs, Office of Regulatory. "Enforcement Reports - Enforcement Report for July 7, 2010". www.fda.gov. Retrieved 1 June 2017.